Hakimeh Gavzan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hakimeh Gavzan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Sayyah
Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran.
3 shared publications - Atefeh Araghi
Faculty of Veterinary Medicine, Amol University of Special Modern Technologies, Amol, Iran
2 shared publications Atefeh Araghi
Amol Univ Special Modern Technol, Fac Vet Med, Dept Clin Sci, Amol, Iran
1 shared publicationBehrokh Marzban Abbasabadi
Amol Univ Special Modern Technol, Fac Vet Med, Dept Basic Sci, Amol, Iran
1 shared publicationForouzan Hashemi
Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran
1 shared publicationHannaneh Golshahi
ACERCR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 6 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
The anti-nociceptive and anti-inflammatory effects of Pelargonium graveolens essential oil nanoemulsion in mice
Pain and inflammation are the severe problems of the world. Essential oils (EOs) have been considered for treating pain and inflammation. As EOs are unstable and insoluble in water, nanoemulsions can improve bioavailability and efficacy. This study formulated Pelargonium graveolens essential oil nanoemulsion (PGEO-NE) using Tween 80 as a carrier. The activity of PGEO-NE (50 and 100 mg/kg) and the involvement of the opioid pathway were investigated in different models of nociception and inflammation in mice. The droplets in PGEO-NE are spherical, with a particle size of around 553 nm and a polydispersity index of 0.113. GC/MS analysis of PGEO revealed citronellol (34.9%), geraniol (16.1%), citronellyl formate (12.3%), and linalool (6.8%) as the main constituents. PGEO-NE significantly reduced the duration of formalin-induced paw licking/biting in both phases and the number of acetic acid-induced writhings, and increased the hot plate latency, compared to vehicle and PGEO (10 mg/kg), equivalent to the PGEO-NE dose of 100 mg/kg. The anti-nociceptive potential of PGEO-NE (100 mg/kg) in the hot plate and acetic acid tests was reversed by the opioid antagonist. After formalin and carrageenan injections, PGEO-NE significantly inhibited paw edema, but PGEO (10 mg/kg) had no effect. These results confirm that PGEO-NE inhibits pain and inflammation via the opioid pathway.
- 6 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessThe anti-nociceptive and anti-inflammatory effects of Pelargonium graveolens essential oil nanoemulsion in mice
Pain and inflammation are the severe problems of the world. Essential oils (EOs) have been considered for treating pain and inflammation. As EOs are unstable and insoluble in water, nanoemulsions can improve bioavailability and efficacy. This study formulated Pelargonium graveolens essential oil nanoemulsion (PGEO-NE) using Tween 80 as a carrier. The activity of PGEO-NE (50 and 100 mg/kg) and the involvement of the opioid pathway were investigated in different models of nociception and inflammation in mice. The droplets in PGEO-NE are spherical, with a particle size of around 553 nm and a polydispersity index of 0.113. GC/MS analysis of PGEO revealed citronellol (34.9%), geraniol (16.1%), citronellyl formate (12.3%), and linalool (6.8%) as the main constituents. PGEO-NE significantly reduced the duration of formalin-induced paw licking/biting in both phases and the number of acetic acid-induced writhings, and increased the hot plate latency, compared to vehicle and PGEO (10 mg/kg), equivalent to the PGEO-NE dose of 100 mg/kg. The anti-nociceptive potential of PGEO-NE (100 mg/kg) in the hot plate and acetic acid tests was reversed by the opioid antagonist. After formalin and carrageenan injections, PGEO-NE significantly inhibited paw edema, but PGEO (10 mg/kg) had no effect. These results confirm that PGEO-NE inhibits pain and inflammation via the opioid pathway.
- Open Access
- 11 August 2024
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 11 (3)
Relationship Between Women's Employment and the Pregnancy Rate in Married Women Receiving Services from Health Centers
Background: Women's employment is a significant factor influencing women's decisions regarding pregnancy, both socially and economically. Objectives: The purpose of this study is to determine the frequency of the decision to get pregnant and the effect of women's employment on this decision. Methods: This descriptive-analytical cross-sectional study was conducted in 2023 in Fereydunkenar, Mazandaran province, Iran. A total of 334 participants were selected using a convenience sampling method. Data were collected using a researcher-made questionnaire, validated and tested for reliability. The validity was confirmed by 4 gynecologists, 3 family medicine specialists, 2 midwives, 1 psychologist, 1 epidemiologist, 1 biostatistics expert, and 1 occupational health expert. Reliability was established through a pilot study with 30 participants, determining Cronbach's alpha. Statistical analysis was performed using SPSS version 26, employing chi-square and multivariate logistic regression tests. Results: The study included 261 working women and 73 housewives. The frequency of deciding to get pregnant was lower among working women compared to housewives (36% vs. 56.2%). The results indicated that having one child increased the odds of not wanting to get pregnant by 2.59 times (OR = 2.59, CI 95%: 1.36 - 4.93, P = 0.004). Having two children increased the odds by six times compared to having no children (OR = 6.00, CI 95%: 2.47-12.70, P = 0.001). Additionally, the desire to migrate increased the odds of not wanting to get pregnant by 3.23 times (OR = 3.23, CI 95%: 1.64 - 6.36, P = 0.001). A distance of more than 5 km from residence to workplace increased the odds by 1.82 times (OR = 1.82, CI 95%: 1.03 - 3.35, P = 0.04), and working more than 7 hours a day increased the odds by 1.95 times (OR = 1.95, CI 95%: 1.10 - 3.43, P = 0.02). Conclusions: The results showed that employment reduces the likelihood of deciding to get pregnant by about half. Therefore, in designing policies to encourage childbirth and address population aging, these barriers should be minimized. Strategies should include reducing the distance between home and workplace, decreasing working hours for women, creating favorable economic and social conditions to reduce migration, and conducting educational programs to shorten the gap between marriage and the birth of the first child.
- 11 August 2024
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 11 (3)
Open AccessRelationship Between Women's Employment and the Pregnancy Rate in Married Women Receiving Services from Health Centers
Background: Women's employment is a significant factor influencing women's decisions regarding pregnancy, both socially and economically. Objectives: The purpose of this study is to determine the frequency of the decision to get pregnant and the effect of women's employment on this decision. Methods: This descriptive-analytical cross-sectional study was conducted in 2023 in Fereydunkenar, Mazandaran province, Iran. A total of 334 participants were selected using a convenience sampling method. Data were collected using a researcher-made questionnaire, validated and tested for reliability. The validity was confirmed by 4 gynecologists, 3 family medicine specialists, 2 midwives, 1 psychologist, 1 epidemiologist, 1 biostatistics expert, and 1 occupational health expert. Reliability was established through a pilot study with 30 participants, determining Cronbach's alpha. Statistical analysis was performed using SPSS version 26, employing chi-square and multivariate logistic regression tests. Results: The study included 261 working women and 73 housewives. The frequency of deciding to get pregnant was lower among working women compared to housewives (36% vs. 56.2%). The results indicated that having one child increased the odds of not wanting to get pregnant by 2.59 times (OR = 2.59, CI 95%: 1.36 - 4.93, P = 0.004). Having two children increased the odds by six times compared to having no children (OR = 6.00, CI 95%: 2.47-12.70, P = 0.001). Additionally, the desire to migrate increased the odds of not wanting to get pregnant by 3.23 times (OR = 3.23, CI 95%: 1.64 - 6.36, P = 0.001). A distance of more than 5 km from residence to workplace increased the odds by 1.82 times (OR = 1.82, CI 95%: 1.03 - 3.35, P = 0.04), and working more than 7 hours a day increased the odds by 1.95 times (OR = 1.95, CI 95%: 1.10 - 3.43, P = 0.02). Conclusions: The results showed that employment reduces the likelihood of deciding to get pregnant by about half. Therefore, in designing policies to encourage childbirth and address population aging, these barriers should be minimized. Strategies should include reducing the distance between home and workplace, decreasing working hours for women, creating favorable economic and social conditions to reduce migration, and conducting educational programs to shorten the gap between marriage and the birth of the first child.
- Open Access
- 1 September 2023
- Vol. 13 (5) , 562-574
Antidepressant effects of a Persian herbal formula on mice with chronic unpredictable mild stress
Objective: Depression is a serious mental disorder. Despite numerous medications, there are still limitations in depression treatment. So, herbal medicine has been considered an alternative therapy. This survey evaluated the effects of a Persian herbal formula on mice with chronic unpredictable mild stress (CUMS). Materials and Methods: A combination of Aloysia triphylla citrodora, Citrus aurantium, Echium amoneum, Lavandula angustifolia, Melissa officinalis, Salix aegyptiaca, Valeriana officinalis, Viola odorata, and Cinnamomum zeylanicum was prepared. Except for the control group, animals were subjected to CUMS for 8 weeks in 5 groups (n=10): CUMS, vehicle (distilled water), herbal formula (0.23 ml/mouse), fluoxetine (20 mg/kg), and bupropion (15 mg/kg). All administrations were performed orally daily for the last 4 weeks. The depression and anxiety-like behaviors were assessed by sucrose preference (SPT), tail suspension (TST), forced swimming (FST), and elevated plus -maze (EPM) tests. Superoxidase-dismutase (SOD) activities in tissues, and serum levels of cortisol, alanine-aminotransferase (ALT), and creatinine were measured. Also, histopathological changes were evaluated. Results: This formula significantly increased SPT (p<0.001) and decreased immobility time in FST and TST (p<0.01), but it was not effective on EPM vs. CUMS mice. The herbal formula did not change the serum level of creatinine or ALT, but insignificantly reduced cortisol vs. CUMS and vehicle groups. SOD activity increased in the brain vs. vehicle group (p<0.05). There were no changes in histological examination. Conclusion: The herbal formula improved depression-like behaviors which are possibly related to its anti-oxidative effect on the brain. Also, it did not cause any negative changes in the biochemical and histopathological analysis.
- 1 September 2023
- Vol. 13 (5) , 562-574
Open AccessAntidepressant effects of a Persian herbal formula on mice with chronic unpredictable mild stress
Objective: Depression is a serious mental disorder. Despite numerous medications, there are still limitations in depression treatment. So, herbal medicine has been considered an alternative therapy. This survey evaluated the effects of a Persian herbal formula on mice with chronic unpredictable mild stress (CUMS). Materials and Methods: A combination of Aloysia triphylla citrodora, Citrus aurantium, Echium amoneum, Lavandula angustifolia, Melissa officinalis, Salix aegyptiaca, Valeriana officinalis, Viola odorata, and Cinnamomum zeylanicum was prepared. Except for the control group, animals were subjected to CUMS for 8 weeks in 5 groups (n=10): CUMS, vehicle (distilled water), herbal formula (0.23 ml/mouse), fluoxetine (20 mg/kg), and bupropion (15 mg/kg). All administrations were performed orally daily for the last 4 weeks. The depression and anxiety-like behaviors were assessed by sucrose preference (SPT), tail suspension (TST), forced swimming (FST), and elevated plus -maze (EPM) tests. Superoxidase-dismutase (SOD) activities in tissues, and serum levels of cortisol, alanine-aminotransferase (ALT), and creatinine were measured. Also, histopathological changes were evaluated. Results: This formula significantly increased SPT (p<0.001) and decreased immobility time in FST and TST (p<0.01), but it was not effective on EPM vs. CUMS mice. The herbal formula did not change the serum level of creatinine or ALT, but insignificantly reduced cortisol vs. CUMS and vehicle groups. SOD activity increased in the brain vs. vehicle group (p<0.05). There were no changes in histological examination. Conclusion: The herbal formula improved depression-like behaviors which are possibly related to its anti-oxidative effect on the brain. Also, it did not cause any negative changes in the biochemical and histopathological analysis.
- Open Access
- 21 August 2023
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 18 (3)
The Protective Effects of the Echium amoenum Seed Oil Against Seizures Induced by Pentylenetetrazole
Background: Many recent studies have documented that polyunsaturated fatty acids (PUFAs) as a safe supplement raise seizure thresholds. However, the evidence of seed oil supplements on seizure susceptibility remains controversial, and among them, Echium seed oil (EO) is a mixture of ω-3 and ω-6 PUFAs. Objectives: This study aimed to test the effects of the sub-chronic administration of EO on intravenous pentylenetetrazole (PTZ) seizure threshold, considering its antioxidant activity and biochemical parameters. Methods: Fifty male mice were divided into five groups (10 in each), including control (no treatment), vehicle (sesame oil), and EO (1, 3, and 5 g/kg) groups. Vehicle and EO were administered p.o. once a day for four weeks. Then, the intravenous PTZ induced-seizure threshold was determined. Finally, the serum concentration of lipid, creatinine, alanine aminotransferase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and the activity of superoxide dismutase (SOD) was assessed. Results: Pretreatment with EO raised the seizure threshold dose-dependently compared to the vehicle. Pretreatment with EO had no adverse effect on the serum concentration of ALP, AST, ALT, creatinine, high-density lipoprotein (HDL), and low-density lipoprotein (LDL), but at the dosages of 3 and 5 g/kg decreased the concentration of cholesterol, very low-density lipoprotein (VLDL) (P < 0.05), and triglyceride (TG) (P < 0.01). Also, 1 and 3 g/kg of EO improved the activity of SOD (P < 0.01). Conclusions: Pretreatment with EO increases the seizure threshold without negative impacts on the liver and kidney biomarkers, correlated with its positive effects on antioxidant activity and serum lipid profiles.
- 21 August 2023
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 18 (3)
Open AccessThe Protective Effects of the Echium amoenum Seed Oil Against Seizures Induced by Pentylenetetrazole
Background: Many recent studies have documented that polyunsaturated fatty acids (PUFAs) as a safe supplement raise seizure thresholds. However, the evidence of seed oil supplements on seizure susceptibility remains controversial, and among them, Echium seed oil (EO) is a mixture of ω-3 and ω-6 PUFAs. Objectives: This study aimed to test the effects of the sub-chronic administration of EO on intravenous pentylenetetrazole (PTZ) seizure threshold, considering its antioxidant activity and biochemical parameters. Methods: Fifty male mice were divided into five groups (10 in each), including control (no treatment), vehicle (sesame oil), and EO (1, 3, and 5 g/kg) groups. Vehicle and EO were administered p.o. once a day for four weeks. Then, the intravenous PTZ induced-seizure threshold was determined. Finally, the serum concentration of lipid, creatinine, alanine aminotransferase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and the activity of superoxide dismutase (SOD) was assessed. Results: Pretreatment with EO raised the seizure threshold dose-dependently compared to the vehicle. Pretreatment with EO had no adverse effect on the serum concentration of ALP, AST, ALT, creatinine, high-density lipoprotein (HDL), and low-density lipoprotein (LDL), but at the dosages of 3 and 5 g/kg decreased the concentration of cholesterol, very low-density lipoprotein (VLDL) (P < 0.05), and triglyceride (TG) (P < 0.01). Also, 1 and 3 g/kg of EO improved the activity of SOD (P < 0.01). Conclusions: Pretreatment with EO increases the seizure threshold without negative impacts on the liver and kidney biomarkers, correlated with its positive effects on antioxidant activity and serum lipid profiles.
- 22 May 2023
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 20, 1
WITHDRAWN: The Sub-chronic Administration of Echium Oil Attenuates the Seizure Threshold and Improves Antioxidant Activity in Pentylenetetrazol- induced Seizure Model of Mice
The article has been withdrawn at the request of the Corresponding author. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
- 22 May 2023
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 20, 1
WITHDRAWN: The Sub-chronic Administration of Echium Oil Attenuates the Seizure Threshold and Improves Antioxidant Activity in Pentylenetetrazol- induced Seizure Model of Mice
The article has been withdrawn at the request of the Corresponding author. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
- 1 August 2018
- Published by Elsevier in Neuroscience Letters
- Vol. 681, 83-86
A role for peroxisome proliferator-activated receptor α in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole
- 1 August 2018
- Published by Elsevier in Neuroscience Letters
- Vol. 681, 83-86
A role for peroxisome proliferator-activated receptor α in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole
- 16 January 2018
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 22 (9) , 616-624
Docosahexaenoic acid prevents resistance to antiepileptic drugs in two animal models of drug-resistant epilepsy
Objectives: One-third of epileptic patients are resistant to antiepileptic drugs. Few clinical studies with small sample size indicate that polyunsaturated fatty acids could control drug-resistant epilepsy. We examined the efficacy of acute and chronic administration of docosahexaenoic acid (DHA) in two animal models of drug-resistant epilepsies, i.e. 6-Hz psychomotor seizures in mice and lamotrigine (LTG)-resistant kindled rats. Methods: Mice received a single injection of DHA (300 µM, i.c.v.) along with phenytoin (PHT) or LTG (i.p.). Six-Hz electroshock (0.2 milliseconds rectangular pulse width, 3 seconds duration, 44 mA current) was given 15 minutes after DHA, and seizure behaviors were recorded. In LTG-resistant kindled rats, a single dose of DHA (300 µM, i.c.v.) was administered with LTG, and seizure parameters were measured. In chronic treatment, mice received DHA (0.1 g/day, orally) for 30 days. Then, a single dose of LTG or PHT was administered to mice and 6-Hz-induced seizures were recorded. In rats, DHA (1 µM, i.c.v.) was administered during kindling development and effect of LTG in DHA-pretreated LTG-resistant kindled rats was verified. Results: LTG and PHT did not inhibit 6-Hz seizures in mice after single injection of DHA. However, LTG and PHT inhibited 6-Hz seizures in mice that received DHA for 1 month. Acute or chronic administration of DHA to LTG-resistant kindled rats led to the suppression of kindled seizure parameters by LTG. Discussion: DHA removes the ‘inherent resistance’ of 6-Hz seizures to PHT and LTG, and prevents the development of pharmacodynamic tolerance to LTG in LTG-resistant kindled rats. DHA might have potential to be used as add-on therapy in patients with refractory epilepsy.
- 16 January 2018
- Published by Taylor & Francis in Nutritional Neuroscience
- Vol. 22 (9) , 616-624
Docosahexaenoic acid prevents resistance to antiepileptic drugs in two animal models of drug-resistant epilepsy
Objectives: One-third of epileptic patients are resistant to antiepileptic drugs. Few clinical studies with small sample size indicate that polyunsaturated fatty acids could control drug-resistant epilepsy. We examined the efficacy of acute and chronic administration of docosahexaenoic acid (DHA) in two animal models of drug-resistant epilepsies, i.e. 6-Hz psychomotor seizures in mice and lamotrigine (LTG)-resistant kindled rats. Methods: Mice received a single injection of DHA (300 µM, i.c.v.) along with phenytoin (PHT) or LTG (i.p.). Six-Hz electroshock (0.2 milliseconds rectangular pulse width, 3 seconds duration, 44 mA current) was given 15 minutes after DHA, and seizure behaviors were recorded. In LTG-resistant kindled rats, a single dose of DHA (300 µM, i.c.v.) was administered with LTG, and seizure parameters were measured. In chronic treatment, mice received DHA (0.1 g/day, orally) for 30 days. Then, a single dose of LTG or PHT was administered to mice and 6-Hz-induced seizures were recorded. In rats, DHA (1 µM, i.c.v.) was administered during kindling development and effect of LTG in DHA-pretreated LTG-resistant kindled rats was verified. Results: LTG and PHT did not inhibit 6-Hz seizures in mice after single injection of DHA. However, LTG and PHT inhibited 6-Hz seizures in mice that received DHA for 1 month. Acute or chronic administration of DHA to LTG-resistant kindled rats led to the suppression of kindled seizure parameters by LTG. Discussion: DHA removes the ‘inherent resistance’ of 6-Hz seizures to PHT and LTG, and prevents the development of pharmacodynamic tolerance to LTG in LTG-resistant kindled rats. DHA might have potential to be used as add-on therapy in patients with refractory epilepsy.
- 29 May 2015
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 388 (10) , 1029-1038
Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models
Add-on therapy is a common strategy to improve efficacy and tolerability of antiepileptic drugs (AEDs). Anticonvulsant potential and appropriate safety of docosahexaenoic acid (DHA) makes it a promising candidate for combination therapy. We evaluated influence of DHA on anticonvulsant activity of AEDs phenytoin, valproate, and lamotrigine in maximal electroshock (MES), pentylenetetrazole (PTZ), and kindling models of epilepsy. The dose–response to DHA was obtained 15 min after intracerebroventricular (i.c.v.) injection in PTZ model of clonic seizures in mice, MES model of tonic seizures in mice, and kindling model of complex partial seizures in rats. The dose–response curve of valproate (30 min after i.p. injection to mice) in PTZ, phenytoin (60 min after i.p. injection to mice) in MES, and lamotrigine (60 min after i.p. injection to rats) in kindling models were obtained. Dose–response curves of the AEDs were then achieved in the presence of ED25 of DHA. DHA had no anticonvulsant effect in the MES model. However, it showed a dose-dependent protective effect against PTZ (ED50 = 0.13 μM) and kindled seizures (ED50 = 1.08 mM). DHA at ED25 caused a 3.6-fold increase in potency of valproate as its ED50 value from 117.5 (98.3–135.3) decreased to 32.5 (21.6–44.1) mg/kg. Moreover, a 4.9-fold increase in potency of lamotrigine occurred, as its ED50 value from 13.10 (11.50–14.9) decreased to 2.65 (0.8–5.6) mg/kg. CompuSyn analysis indicated synergistic anticonvulsant interaction between DHA and both valproate and lamotrigine. Co-administration strategy of the safe and inexpensive anticonvulsant compound DHA with AEDs should be favorably regarded in clinical studies of epilepsy treatment.
- 29 May 2015
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 388 (10) , 1029-1038
Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models
Add-on therapy is a common strategy to improve efficacy and tolerability of antiepileptic drugs (AEDs). Anticonvulsant potential and appropriate safety of docosahexaenoic acid (DHA) makes it a promising candidate for combination therapy. We evaluated influence of DHA on anticonvulsant activity of AEDs phenytoin, valproate, and lamotrigine in maximal electroshock (MES), pentylenetetrazole (PTZ), and kindling models of epilepsy. The dose–response to DHA was obtained 15 min after intracerebroventricular (i.c.v.) injection in PTZ model of clonic seizures in mice, MES model of tonic seizures in mice, and kindling model of complex partial seizures in rats. The dose–response curve of valproate (30 min after i.p. injection to mice) in PTZ, phenytoin (60 min after i.p. injection to mice) in MES, and lamotrigine (60 min after i.p. injection to rats) in kindling models were obtained. Dose–response curves of the AEDs were then achieved in the presence of ED25 of DHA. DHA had no anticonvulsant effect in the MES model. However, it showed a dose-dependent protective effect against PTZ (ED50 = 0.13 μM) and kindled seizures (ED50 = 1.08 mM). DHA at ED25 caused a 3.6-fold increase in potency of valproate as its ED50 value from 117.5 (98.3–135.3) decreased to 32.5 (21.6–44.1) mg/kg. Moreover, a 4.9-fold increase in potency of lamotrigine occurred, as its ED50 value from 13.10 (11.50–14.9) decreased to 2.65 (0.8–5.6) mg/kg. CompuSyn analysis indicated synergistic anticonvulsant interaction between DHA and both valproate and lamotrigine. Co-administration strategy of the safe and inexpensive anticonvulsant compound DHA with AEDs should be favorably regarded in clinical studies of epilepsy treatment.